Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CHRSCoherus Oncology, Inc.

Nasdaq · CIK 0001512762
Filer categoryAccelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts521

Identity from submissions API

NameCoherus Oncology, Inc.
CIK0001512762
TickersCHRS
ExchangesNasdaq
Entity typeoperating
CategoryAccelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN273615821
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(650) 649-3530
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Coherus BioSciences, Inc. (2013-01-14T05:00:00.000Z → 2025-05-28T04:00:00.000Z)
  • BioGenerics, Inc. (2011-02-23T05:00:00.000Z → 2012-01-03T05:00:00.000Z)
Business address
C/O DENNIS M. LANFEAR
333 TWIN DOLPHIN DR, SUITE 600
REDWOOD CITY
CA
94065
CA
Mailing address
C/O DENNIS M. LANFEAR
333 TWIN DOLPHIN DR, SUITE 600
REDWOOD CITY
CA
94065
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

923 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-09 10-Q 10-Q 0001104659-26-124572 001-36721 261536799 34 11323333 1 1
2026-11-09 8-K 8-K 2.02,9.01 0001104659-26-124511 001-36721 261536259 34 1165766 1 1
2026-10-29 8-K 8-K 7.01,8.01,9.01 0001104659-26-119912 001-36721 261497628 34 1805292 1 1
2026-08-28 8-K 8-K 8.01,9.01 0001104659-26-103316 001-36721 261341425 34 625874 1 1
2026-08-28 424B5 424B5 0001104659-26-103241 333-291520 261340885 33 432219
2026-08-28 424B3 424B3 0001104659-26-103239 333-291520 261340848 33 36691
2026-08-17 8-K 8-K 7.01,8.01,9.01 0001104659-26-097951 001-36721 261287711 34 467802 1 1
2026-08-17 8-K 8-K 1.01,1.02,2.03,9.01 0001104659-26-097949 001-36721 261287709 34 1001484 1 1
2026-08-05 S-8 S-8 0001104659-26-091276 333-298029 261244925 33 318976 1 1
2026-08-05 10-Q 10-Q 0001104659-26-091262 001-36721 261244804 34 9496099 1 1
2026-08-05 8-K 8-K 2.02,9.01 0001104659-26-091188 001-36721 261244332 34 493189 1 1
2026-07-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002236 005-88402 261206057 34 11191
2026-06-15 8-K 8-K 4.01,9.01 0001104659-26-074090 001-36721 261091424 34 170731 1 1
2026-06-09 4 xslF345X06/form4.xml 0001610717-26-000206 7407
2026-06-09 4 xslF345X06/form4.xml 0001610717-26-000205 7361
2026-06-09 4 xslF345X06/form4.xml 0001610717-26-000204 7367
2026-06-09 4 xslF345X06/form4.xml 0001610717-26-000203 7417
2026-06-09 4 xslF345X06/form4.xml 0001610717-26-000202 7429
2026-06-09 4 xslF345X06/form4.xml 0001610717-26-000201 7361
2026-06-09 4 xslF345X06/form4.xml 0001610717-26-000200 7358
2026-06-02 4 OWNERSHIP DOCUMENT 0001104659-26-069622 31145
2026-06-02 4 OWNERSHIP DOCUMENT 0001104659-26-069621 43325
2026-06-01 8-K 8-K 5.07 0001104659-26-068615 001-36721 261047407 34 196779 1 1
2026-05-28 DEFA14A DEFA14A 0001104659-26-067154 001-36721 261028413 34 26539
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002109159-26-000003 005-88402 26983363 34 8395
2026-05-11 10-Q 10-Q 0001104659-26-058703 001-36721 26963978 34 8241502 1 1
2026-05-11 8-K 8-K 2.02,9.01 0001104659-26-058666 001-36721 26963439 34 393545 1 1
2026-05-11 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002109159-26-000002 005-88402 26961168 34 6769
2026-05-05 DEFA14A DEFA14A 0001104659-26-055695 001-36721 26944119 34 10661
2026-04-29 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-051922 005-88402 26919428 34 8891
2026-04-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-001679 005-88402 26901053 34 11242
2026-04-20 ARS ARS 0001104659-26-045272 001-36721 26873485 34 1286462
2026-04-20 DEF 14A DEF 14A 0001104659-26-045251 001-36721 26873439 34 2784796 1 1
2026-04-14 DEFA14A DEFA14A 0001104659-26-043317 001-36721 26861736 34 15758
2026-04-09 PRE 14A PRE 14A 0001104659-26-041578 001-36721 26852612 34 2246455 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000907 005-88402 26799312 34 7624
2026-03-09 10-K 10-K 0001104659-26-025308 001-36721 26735912 34 15416299 1 1
2026-03-09 8-K 8-K 2.02,9.01 0001104659-26-025293 001-36721 26735687 34 534869 1 1
2026-02-17 8-K 8-K 8.01,9.01 0001104659-26-016378 001-36721 26640940 34 563840 1 1
2026-02-13 424B5 424B5 0001104659-26-015358 333-291520 26634483 33 723008
2026-02-12 424B5 424B5 0001104659-26-014280 333-291520 26626231 33 724048
2026-02-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002109159-26-000001 005-88402 26601063 34 8614
2026-02-04 8-K 8-K 8.01 0001104659-26-010065 001-36721 26596127 34 156528 1 1
2026-01-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000318 005-88402 26583003 34 7466
2026-01-26 4 xslF345X05/form4.xml 0001610717-26-000027 9276
2026-01-26 4 xslF345X05/form4.xml 0001610717-26-000026 7524
2026-01-23 8-K FORM 8-K 8.01,9.01 0001104659-26-006307 001-36721 26557823 34 231336 1 1
2026-01-23 424B5 424B5 0001104659-26-006306 333-291520 26557803 33 433984
2026-01-22 4 xslF345X05/form4.xml 0001610717-26-000017 4982
2026-01-22 4 xslF345X05/form4.xml 0001610717-26-000016 6735
2026-01-13 8-K 8-K 2.02,9.01 0001104659-26-003117 001-36721 26528557 34 790152 1 1
2025-12-08 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003584 333-291520 251557518 33 2023
2025-12-05 CORRESP filename1.htm 0001104659-25-118941 8285
2025-11-13 S-3 S-3 0001104659-25-111503 333-291520 251479928 33 1056708 1 1
2025-11-13 S-8 FORM S-8 0001104659-25-111492 333-291519 251479844 33 209896 1 1
2025-11-13 8-K 8-K 8.01,9.01 0001104659-25-111484 001-36721 251479737 34 16454992 1 1
2025-11-06 10-Q 10-Q 0001104659-25-107852 001-36721 251459525 34 11015955 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001104659-25-107780 001-36721 251458876 34 533681 1 1
2025-11-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-106487 005-88402 251451135 34 21691
2025-09-08 8-K 8-K 8.01 0001558370-25-011911 001-36721 251298822 34 158156 1 1
2025-08-07 10-Q 10-Q 0001558370-25-010803 001-36721 251195071 34 11415806 1 1
2025-08-07 8-K 8-K 2.02,9.01 0001558370-25-010802 001-36721 251195044 34 548006 1 1
2025-07-03 8-K 8-K 3.01 0001558370-25-009085 001-36721 251105645 34 160879 1 1
2025-06-13 4 xslF345X05/form4.xml 0001610717-25-000229 5515
2025-06-13 4 xslF345X05/form4.xml 0001610717-25-000228 5450
2025-06-13 4 xslF345X05/form4.xml 0001610717-25-000227 5444
2025-06-13 4 xslF345X05/form4.xml 0001610717-25-000226 5500
2025-06-13 4 xslF345X05/form4.xml 0001610717-25-000225 5444
2025-06-13 4 xslF345X05/form4.xml 0001610717-25-000224 5431
2025-06-13 4 xslF345X05/form4.xml 0001610717-25-000223 5441
2025-06-13 4 xslF345X05/form4.xml 0001610717-25-000222 5490
2025-06-13 8-K FORM 8-K 5.07 0001104659-25-059351 001-36721 251046571 34 201723 1 1
2025-05-30 8-K 8-K 5.03,7.01,9.01 0001558370-25-008294 001-36721 251010801 34 459535 1 1
2025-05-28 4 xslF345X05/form4.xml 0001610717-25-000145 5561
2025-05-15 SC TO-I/A SC TO-I/A 0001104659-25-049551 005-88402 25954633 34 39711
2025-05-12 10-Q 10-Q 0001558370-25-007418 001-36721 25935790 34 9290389 1 1
2025-05-12 8-K 8-K 2.02,9.01 0001558370-25-007410 001-36721 25935521 34 416850 1 1
2025-05-09 4 xslF345X05/form4.xml 0001610717-25-000117 5586
2025-05-09 4 xslF345X05/form4.xml 0001610717-25-000116 5584
2025-04-29 ARS ARS 0001558370-25-005835 001-36721 25887473 34 1525855
2025-04-29 DEFA14A DEFA14A 0001558370-25-005831 001-36721 25887222 34 380378
2025-04-29 DEF 14A DEF 14A 0001558370-25-005825 001-36721 25887117 34 2486819 1 1
2025-04-25 8-K 8-K 5.02 0001558370-25-005554 001-36721 25873803 34 191501 1 1
2025-04-22 8-K 8-K 5.02 0001558370-25-005157 001-36721 25858449 34 165782 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000578 005-88402 25844515 34 11040
2025-04-16 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-035581 005-88402 25843718 34 8567
2025-04-16 SC TO-I SC TO-I 0001104659-25-035503 005-88402 25842966 34 253670
2025-04-14 8-K 8-K 2.01,7.01,9.01 0001558370-25-004746 001-36721 25834239 34 832787 1 1
2025-04-01 8-K 8-K 1.01,8.01,9.01 0001558370-25-004264 001-36721 25799708 34 276181 1 1
2025-03-17 10-K 10-K 0001558370-25-003126 001-36721 25744888 34 18567710 1 1
2025-03-13 8-K 8-K 5.07 0001558370-25-002842 001-36721 25733663 34 202460 1 1
2025-03-10 8-K 8-K 2.02,9.01 0001558370-25-002595 001-36721 25724221 34 642018 1 1
2025-03-04 DEFA14A DEFA14A 0001558370-25-002119 001-36721 25701679 34 182473
2025-03-04 8-K 8-K 8.01 0001558370-25-002117 001-36721 25701677 34 316515 1 1
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-012904 005-88402 25620005 34 10491
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001197 005-88402 25592197 34 12088
2025-01-30 DEFA14A DEFA14A 0001104659-25-007330 001-36721 25570774 34 1238035
2025-01-28 DEFM14A DEFM14A 0001104659-25-006774 001-36721 25565840 34 3723148
2025-01-22 4 xslF345X05/form4.xml 0001610717-25-000015 4892
2025-01-22 4 xslF345X05/form4.xml 0001610717-25-000014 4837
2025-01-22 4 xslF345X05/form4.xml 0001610717-25-000013 6649
2025-01-14 4 xslF345X05/form4.xml 0001610717-25-000011 5594
2025-01-14 PREM14A PREM14A 0001104659-25-003440 001-36721 25529445 34 3285736
2025-01-14 DEFA14A DEFA14A 0001104659-25-003176 001-36721 25527485 34 27383583
2025-01-13 8-K 8-K 2.02,7.01,9.01 0001558370-25-000167 001-36721 25526637 34 450098 1 1
2025-01-10 4 xslF345X05/form4.xml 0001610717-25-000010 5090
2025-01-07 4 xslF345X05/form4.xml 0001610717-25-000009 6649
2025-01-07 4 xslF345X05/form4.xml 0001610717-25-000008 5591
2025-01-07 4 xslF345X05/form4.xml 0001610717-25-000007 7291
2024-12-17 4 xslF345X05/form4.xml 0001610717-24-000542 5089
2024-12-04 8-K 8-K 5.02 0001558370-24-016012 001-36721 241526545 34 189994 1 1
2024-12-04 DEFA14A DEFA14A 0001104659-24-125540 001-36721 241526530 34 604936
2024-12-04 DEFA14A DEFA14A 0001104659-24-125205 001-36721 241524341 34 104014
2024-12-03 DEFA14A DEFA14A 0001104659-24-125129 001-36721 241523771 34 249143
2024-12-03 DEFA14A DEFA14A 0001104659-24-124882 001-36721 241521060 34 665607
2024-12-03 8-K FORM 8-K 1.01,7.01,9.01 0001104659-24-124881 001-36721 241521057 34 983761 1 1
2024-11-13 SC 13G SC 13G 0001104659-24-117741 005-88402 241454869 34 77466
2024-11-06 10-Q 10-Q 0001558370-24-014648 001-36721 241431553 34 12369276 1 1
2024-11-06 8-K 8-K 2.02,9.01 0001558370-24-014642 001-36721 241431408 34 597006 1 1
2024-09-13 8-K 8-K 7.01 0001558370-24-012783 001-36721 241298602 34 204496 1 1
2024-09-13 UPLOAD filename1.pdf 0000000000-24-010371 001-36721 39959
2024-09-06 CORRESP filename1.htm 0001558370-24-012653 11819
2024-08-23 UPLOAD filename1.pdf 0000000000-24-009669 001-36721 43352
2024-08-09 4 xslF345X05/form4.xml 0001610717-24-000424 5588
2024-08-08 S-8 S-8 0001193125-24-197039 333-281394 241189237 33 235376
2024-08-08 10-Q 10-Q 0001558370-24-011629 001-36721 241189124 34 12408721 1 1
2024-08-08 8-K 8-K 2.02,5.02,9.01 0001558370-24-011618 001-36721 241188794 34 591832 1 1
2024-07-24 4 xslF345X05/form4.xml 0001610717-24-000406 5527
2024-07-24 4 xslF345X05/form4.xml 0001610717-24-000405 5466
2024-07-23 SC 13G/A SC 13G/A 0001193125-24-182603 005-88402 241133004 34 89768
2024-07-02 8-K 8-K 1.01 0001558370-24-009650 001-36721 241092974 34 192589 1 1
2024-06-27 8-K 8-K 1.01,2.01,8.01,9.01 0001558370-24-009526 001-36721 241075579 34 1341423 1 1
2024-06-05 4 xslF345X05/form4.xml 0001610717-24-000295 5433
2024-06-05 3 xslF345X02/form3.xml 0001610717-24-000294 9115
2024-06-05 4 xslF345X05/form4.xml 0001610717-24-000293 5420
2024-06-05 4 xslF345X05/form4.xml 0001610717-24-000292 5348
2024-06-05 4 xslF345X05/form4.xml 0001610717-24-000291 5407
2024-06-05 4 xslF345X05/form4.xml 0001610717-24-000290 5351
2024-06-05 4 xslF345X05/form4.xml 0001610717-24-000289 5335
2024-06-05 4 xslF345X05/form4.xml 0001610717-24-000288 5357
2024-06-05 4 xslF345X05/form4.xml 0001610717-24-000287 5363
2024-06-05 4 xslF345X05/form4.xml 0001610717-24-000286 5422
2024-06-05 8-K 8-K 5.02 0001558370-24-008918 001-36721 241020942 34 166768 1 1
2024-06-04 8-K 8-K 5.07 0001558370-24-008898 001-36721 241017913 34 196879 1 1
2024-05-22 SC 13G/A SC 13G/A 0001193125-24-145183 005-88402 24974901 34 98514
2024-05-21 8-K/A 8-K/A 9.01 0001558370-24-008542 001-36721 24970643 34 1930042 1 1
2024-05-13 DEFA14A DEFA14A 0001558370-24-007976 001-36721 24939671 34 78718
2024-05-09 10-Q 10-Q 0001558370-24-007641 001-36721 24931568 34 10184979 1 1
2024-05-09 8-K 8-K 2.02,9.01 0001558370-24-007622 001-36721 24930938 34 405312 1 1
2024-05-09 8-K 8-K 1.01,1.02,2.03 0001558370-24-007468 001-36721 24928580 34 174703 1 1
2024-04-15 ARS ARS 0001558370-24-005133 001-36721 24845410 34 2031124
2024-04-15 DEFA14A DEFA14A 0001558370-24-005132 001-36721 24845401 34 406796
2024-04-15 DEF 14A DEF 14A 0001558370-24-005131 001-36721 24845394 34 3641903 1 1
2024-03-28 S-8 S-8 0001193125-24-080568 333-278314 24798756 33 82588
2024-03-15 10-K 10-K 0001558370-24-003436 001-36721 24755904 34 20492908 1 1
2024-03-13 8-K 8-K 2.02,9.01 0001558370-24-003110 001-36721 24746125 34 521457 1 1
2024-03-04 8-K 8-K 2.01,2.04,8.01,9.01 0001558370-24-002306 001-36721 24712779 34 834362 1 1
2024-02-22 4 xslF345X05/form4.xml 0001610717-24-000088 5375
2024-02-22 3 xslF345X02/form3.xml 0001610717-24-000086 9613
2024-02-22 8-K 8-K 5.02 0001558370-24-001542 001-36721 24665825 34 165757 1 1
2024-02-15 4 xslF345X05/form4.xml 0001610717-24-000060 6398
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023964 005-88402 24640018 34 137993
2024-02-14 SC 13G/A SEC SCHEDULE 13G 0001532155-24-000049 005-88402 24636462 34 18389
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020641 005-88402 24628020 34 13242
2024-02-05 4 xslF345X05/form4.xml 0001610717-24-000044 10132
2024-02-05 8-K 8-K 1.01,7.01,9.01 0001558370-24-000740 001-36721 24594004 34 324985 1 1
2024-01-24 SC 13G/A us19249h1032_012324.txt 0001086364-24-002035 005-88402 24554576 34 13852
2024-01-23 4 xslF345X05/form4.xml 0001610717-24-000039 6649
2024-01-23 4 xslF345X05/form4.xml 0001610717-24-000038 4837
2024-01-23 4 xslF345X05/form4.xml 0001610717-24-000037 5036
2024-01-22 SC 13G/A Coherus_Bio_Inc.txt 0000093751-24-000072 005-88402 24548279 34 8692
2024-01-22 8-K 8-K 1.01,7.01,9.01 0001193125-24-011700 001-36721 24547115 34 764172 1 1
2024-01-10 8-K 8-K 2.02,9.01 0001558370-24-000166 001-36721 24524766 34 358122 1 1
2024-01-10 8-K 8-K 8.01 0001558370-24-000165 001-36721 24524762 34 162501 1 1
2024-01-09 4 xslF345X05/form4.xml 0001610717-24-000023 4932
2024-01-08 4 xslF345X05/form4.xml 0001610717-24-000019 8886
2024-01-08 4 xslF345X05/form4.xml 0001610717-24-000018 4733
2024-01-04 4 xslF345X05/form4.xml 0001610717-24-000012 5622
2024-01-04 4 xslF345X05/form4.xml 0001610717-24-000011 5423
2024-01-03 4 xslF345X05/form4.xml 0001610717-24-000001 5015
2023-12-27 8-K FORM 8-K 8.01 0001104659-23-129338 001-36721 231514432 34 200470 1 1
2023-12-15 4 xslF345X05/form4.xml 0001610717-23-000401 4850
2023-12-11 8-K 8-K 5.02 0001558370-23-019713 001-36721 231478267 34 166826 1 1
2023-12-07 8-K 8-K 5.02 0001558370-23-019636 001-36721 231473156 34 161264 1 1
2023-12-07 SC 13G/A FILING COHERUS BIOSCIENCES, INC. 0000019617-23-000585 005-88402 34 89986
2023-11-27 8-K 8-K 7.01 0001558370-23-019328 001-36721 231440297 34 161518 1 1
2023-11-24 4 xslF345X05/form4.xml 0001610717-23-000363 12290
2023-11-22 144 xsl144X01/primary_doc.xml 0001972362-23-001027 001-36721 231434626 33 4407
2023-11-13 8-K/A 8-K/A 9.01 0001193125-23-275207 001-36721 231394689 34 154642 1 1
2023-11-06 10-Q 10-Q 0001558370-23-017779 001-36721 231380439 34 12198368 1 1
2023-11-06 8-K 8-K 2.02,9.01 0001558370-23-017778 001-36721 231380385 34 523979 1 1
2023-11-06 8-K/A 8-K/A 9.01 0001193125-23-270796 001-36721 231377999 34 1018817 1 1
2023-10-27 8-K 8-K 7.01,8.01,9.01 0001558370-23-016949 001-36721 231355839 34 294254 1 1
2023-10-27 8-K 8-K 1.01,2.03 0001558370-23-016946 001-36721 231355530 34 166961 1 1
2023-10-06 8-K 8-K 3.02 0001558370-23-016290 001-36721 231314816 34 163033 1 1
2023-10-06 SC 13G/A us19249h1032_100523.txt 0001306550-23-010091 005-88402 231313864 34 13762
2023-09-12 8-K FORM 8-K 1.01 0001104659-23-099837 001-36721 231248955 34 199795 1 1
2023-09-12 424B5 424B5 0001104659-23-099828 333-268252 231248942 33 520256
2023-09-08 8-K 8-K 2.01,8.01,9.01 0001558370-23-015582 001-36721 231243803 34 235535 1 1
2023-08-02 10-Q 10-Q 0001558370-23-012915 001-36721 231135674 34 9988838 1 1
2023-08-02 8-K 8-K 2.02,9.01 0001558370-23-012903 001-36721 231135505 34 501602 1 1
2023-07-26 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2023-07-26 16:00:00 9999999995-23-002193 333-273179 231115108 33 1885
2023-07-26 424B3 424B3 0001193125-23-194696 333-273179 231114274 33 2600553
2023-07-24 CORRESP filename1.htm 0001193125-23-192311 6858
2023-07-24 S-4/A S-4/A 0001193125-23-192291 333-273179 231105510 33 3150574
2023-07-20 4 xslF345X05/form4.xml 0001610717-23-000207 5360
2023-07-20 3 FORM 3 0001567619-23-006640 9898
2023-07-20 8-K 8-K 5.02 0001558370-23-012028 001-36721 231100408 34 177684 1 1
2023-07-14 UPLOAD filename1.pdf 0000000000-23-007521 40400
2023-07-07 S-4 S-4 0001193125-23-183872 333-273179 231077536 33 2696991
2023-06-16 425 425 0001193125-23-169124 24274
2023-06-16 425 425 0001193125-23-169120 218404
2023-06-16 425 425 0001193125-23-169116 26887
2023-06-16 425 425 0001193125-23-169112 33095
2023-06-16 425 425 0001193125-23-169110 3100431
2023-06-16 425 425 0001193125-23-169107 144751
2023-06-16 425 425 0001193125-23-168499 001-36721 231019390 34 1015233
2023-06-16 425 425 0001193125-23-168454 961031
2023-06-16 8-K 8-K 1.01,7.01,9.01 0001193125-23-168448 001-36721 231019343 34 1307893 1 1
2023-06-15 4 xslF345X04/form4.xml 0001610717-23-000168 5402
2023-06-15 4 xslF345X04/form4.xml 0001610717-23-000167 5549
2023-06-15 4 xslF345X04/form4.xml 0001610717-23-000166 5314
2023-06-15 4 xslF345X04/form4.xml 0001610717-23-000165 5342
2023-06-15 8-K 8-K 8.01 0001193125-23-167305 001-36721 231015892 34 144899 1 1
2023-06-09 4 xslF345X04/form4.xml 0001610717-23-000122 5299
2023-06-09 4 xslF345X04/form4.xml 0001610717-23-000121 5283
2023-06-09 4 xslF345X04/form4.xml 0001610717-23-000120 5305
2023-06-09 8-K 8-K 5.07 0001558370-23-010962 001-36721 231006168 34 203079 1 1
2023-06-09 4 xslF345X04/form4.xml 0001610717-23-000119 5311
2023-06-09 4 xslF345X04/form4.xml 0001610717-23-000118 5370
2023-06-09 4 xslF345X04/form4.xml 0001610717-23-000117 5293
2023-05-31 8-K 8-K 8.01 0001558370-23-010652 001-36721 23980020 34 262810 1 1
2023-05-19 SC 13G SC 13G 0001104659-23-062515 005-88402 23938041 34 151356
2023-05-18 8-K 8-K 8.01,9.01 0001193125-23-148266 001-36721 23936943 34 435180 1 1
2023-05-17 424B5 424B5 0001193125-23-146973 333-268252 23931572 33 597224
2023-05-16 424B5 424B5 0001193125-23-145573 333-268252 23925483 33 600067
2023-05-15 8-K 8-K 1.01 0001193125-23-145220 001-36721 23924477 34 142632 1 1
2023-05-08 10-Q 10-Q 0001558370-23-008529 001-36721 23898048 34 9165086 1 1
2023-05-08 8-K 8-K 2.02,9.01 0001558370-23-008523 001-36721 23897981 34 481171 1 1
2023-04-17 ARS ARS 0001558370-23-006058 001-36721 23824034 34 1516078
2023-04-17 DEFA14A DEFA14A 0001558370-23-006054 001-36721 23824018 34 384797
2023-04-17 DEF 14A DEF 14A 0001558370-23-006050 001-36721 23823984 34 2627762 1 1
2023-04-04 4 xslF345X04/form4.xml 0001140361-23-016457 4891
2023-04-04 4 xslF345X04/form4.xml 0001140361-23-016454 4652
2023-04-04 4 xslF345X04/form4.xml 0001140361-23-016453 4824
2023-03-29 4 xslF345X04/form4.xml 0001140361-23-014545 5611
2023-03-28 3 xslF345X02/form3.xml 0001140361-23-014316 16708
2023-03-06 10-K 10-K 0001558370-23-002917 001-36721 23709124 34 15842159 1 1
2023-03-06 8-K 8-K 2.02,2.05,5.02,9.01 0001558370-23-002912 001-36721 23709051 34 589361 1 1
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-038714 005-88402 23627215 34 63858
2023-02-14 SC 13G/A SEC SCHEDULE 13G 0001532155-23-000078 005-88402 23621008 34 18325
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015665 005-88402 23602838 34 13159
2023-02-03 SC 13G/A Coherus_Biosciences_Inc.txt 0000093751-23-000188 005-88402 23585631 34 10543
2023-01-26 SC 13G/A us19249h1032_012623.txt 0001306550-23-004236 005-88402 23554476 34 13473
2023-01-24 4 FORM 4 0001567619-23-001211 6980
2023-01-24 4 FORM 4 0001567619-23-001210 5418
2023-01-24 4 FORM 4 0001567619-23-001209 5197
2023-01-24 4 FORM 4 0001567619-23-001207 5191
2023-01-20 SC 13G us19249h1032_011923.txt 0001306550-23-000540 005-88402 23539120 34 13436
2023-01-18 S-8 FORM S-8 0001104659-23-004632 333-269291 23534928 33 103270
2023-01-18 SC 13G/A FILING COHERUS BIOSCIENCES, INC. 0000019617-23-000099 005-88402 34 90007
2023-01-13 8-K 8-K 8.01 0001193125-23-007361 001-36721 23526916 34 141982 1 1
2023-01-12 4 FORM 4 0001567619-23-000892 6386
2023-01-10 4 FORM 4 0001567619-23-000765 5342
2023-01-06 4 FORM 4 0001567619-23-000698 9137
2023-01-06 4 FORM 4 0001567619-23-000697 5907
2023-01-06 4 FORM 4 0001567619-23-000696 7543
2023-01-06 4 FORM 4 0001567619-23-000695 7339
2023-01-04 4 FORM 4 0001567619-23-000350 6591
2022-11-18 424B5 424B5 0001104659-22-119958 333-268252 221399815 33 419556
2022-11-17 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-11-17 16:00:00 9999999995-22-003337 333-268252 221400464 33 1885
2022-11-15 CORRESP filename1.htm 0001104659-22-119065 8657
2022-11-14 UPLOAD filename1.pdf 0000000000-22-012352 40379
2022-11-08 S-3 FORM S-3 0001104659-22-116004 333-268252 221369834 33 1146614
2022-11-08 10-Q 10-Q 0001558370-22-016850 001-36721 221368779 34 8530117 1 1
2022-11-08 8-K 8-K 2.02,9.01 0001558370-22-016847 001-36721 221368746 34 480104 1 1
2022-10-06 8-K/A 8-K/A 5.07 0001193125-22-258849 001-36721 221298247 34 147169 1 1
2022-09-15 8-K 8-K 2.03 0001193125-22-245659 001-36721 221246125 34 147665 1 1
2022-09-09 4 FORM 4 0001567619-22-017242 5911
2022-09-09 3 FORM 3 0001567619-22-017241 13587
2022-09-09 8-K 8-K 5.02 0001193125-22-242031 001-36721 221236637 34 147142 1 1
2022-08-04 10-Q 10-Q 0001558370-22-012251 001-36721 221137233 34 8453513 1 1
2022-08-04 8-K 8-K 2.02,9.01 0001558370-22-012225 001-36721 221137020 34 480175 1 1
2022-05-20 8-K 8-K 5.07 0001193125-22-156321 001-36721 22948817 34 152282 1 1
2022-05-20 4 FORM 4 0001567619-22-011419 5707
2022-05-20 3 FORM 3 0001567619-22-011410 10450
2022-05-13 8-K 8-K 5.02 0001193125-22-150187 001-36721 22923516 34 146770 1 1
2022-05-10 8-K 8-K 5.02 0001193125-22-146410 001-36721 22910722 34 145741 1 1
2022-05-06 4 FORM 4 0001567619-22-009712 5629
2022-05-06 3 FORM 3 0001567619-22-009711 9825
2022-05-06 3 FORM 3 0001567619-22-009710 9825
2022-05-05 10-Q 10-Q 0001558370-22-007420 001-36721 22897057 34 7807690 1 1
2022-05-05 8-K 8-K 1.01,2.02,9.01 0001558370-22-007404 001-36721 22896801 34 383701 1 1
2022-04-20 UPLOAD filename1.pdf 0000000000-22-004263 39831
2022-04-20 CORRESP filename1.htm 0001193125-22-111128 8342
2022-04-07 UPLOAD filename1.pdf 0000000000-22-003725 43534
2022-04-05 4 FORM 4 0001567619-22-008114 4955
2022-04-05 4 FORM 4 0001567619-22-008113 4964
2022-04-04 DEFA14A DEFA14A 0001558370-22-005050 001-36721 22802185 34 280872
2022-04-04 DEF 14A DEF 14A 0001558370-22-005048 001-36721 22802106 34 1515048
2022-04-01 8-K 8-K 2.03 0001193125-22-093655 001-36721 22798448 34 147599 1 1
2022-03-01 4 FORM 4 0001567619-22-005922 8252
2022-02-24 S-8 S-8 0001193125-22-050281 333-262941 22665304 33 82883
2022-02-23 10-K 10-K 0001558370-22-001764 001-36721 22665156 34 13982531 1 1
2022-02-17 8-K 8-K 2.02,9.01 0001558370-22-001349 001-36721 22648758 34 508480 1 1
2022-02-15 SC 13G/A SC 13G/A 0001193125-22-042408 005-88402 22635937 34 67976
2022-02-14 SC 13G/A Coherus.htm 0001532155-22-000026 005-88402 22629816 34 18324
2022-02-11 4/A FORM 4/A 0001567619-22-003511 6039
2022-02-11 4/A FORM 4/A 0001567619-22-003508 6008
2022-02-11 4/A FORM 4/A 0001567619-22-003505 6036
2022-02-11 4/A FORM 4/A 0001567619-22-003502 6024
2022-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-016865 005-88402 22606889 34 13154
2022-02-09 SC 13G/A COHERUS_BIOSCIENCES_INC.txt 0000093751-22-000027 005-88402 22605414 34 8605
2022-02-07 8-K 8-K 5.02 0001193125-22-029787 001-36721 22598491 34 150989 1 1
2022-02-04 4 FORM 4 0001567619-22-002564 5650
2022-02-04 3 FORM 3 0001567619-22-002563 10478
2022-01-27 SC 13G/A us19249h1032_012722.txt 0000834237-22-002692 005-88402 22564265 34 13473
2022-01-26 SC 13G/A us19249h1032_012622.txt 0000834237-22-001171 005-88402 22556011 34 13473
2022-01-13 8-K FORM 8-K 1.01,8.01,9.01 0001193125-22-008717 001-36721 22529451 34 187959 1 1
2022-01-13 S-8 REGISTRATION STATEMENT ON FORM S-8 0001193125-22-008079 333-262134 22527787 33 76623
2022-01-12 4 FORM 4 0001567619-22-001114 6770
2022-01-10 4 FORM 4 0001567619-22-000925 5658
2022-01-10 4 FORM 4 0001567619-22-000924 5627
2022-01-10 4 FORM 4 0001567619-22-000923 5655
2022-01-10 4 FORM 4 0001567619-22-000920 5643
2022-01-07 SC 13G/A FILING COHERUS BIOSCIENCES, INC. 0000019617-22-000041 005-88402 34 90060
2022-01-07 8-K 8-K 1.01,1.02,2.03,8.01,9.01 0001193125-22-004051 001-36721 22516561 34 1060343 1 1
2022-01-06 4 FORM 4 0001567619-22-000821 9508
2022-01-06 4 FORM 4 0001567619-22-000820 7895
2022-01-06 4 FORM 4 0001567619-22-000819 7906
2021-12-30 CORRESP filename1.htm 0001193125-21-370825 24675
2021-12-16 UPLOAD filename1.pdf 0000000000-21-015013 44238
2021-12-03 8-K 8-K 5.02 0001193125-21-348020 001-36721 211471258 34 143097 1 1
2021-11-23 4 FORM 4 0001567619-21-021059 6826
2021-11-08 10-Q 10-Q 0001558370-21-015033 001-36721 211388032 34 10230518 1 1
2021-11-08 8-K 8-K 2.02,9.01 0001558370-21-015027 001-36721 211387949 34 469223 1 1
2021-10-19 4 FORM 4 0001567619-21-018470 5012
2021-10-13 8-K 8-K 5.02,9.01 0001193125-21-297915 001-36721 211321785 34 156929 1 1
2021-09-29 4 FORM 4 0001104659-21-120896 10843
2021-09-29 8-K FORM 8-K 5.02,9.01 0001193125-21-286870 001-36721 211292606 34 155408 1 1
2021-08-11 8-K 8-K 5.02 0001193125-21-243344 001-36721 211163362 34 141993 1 1
2021-08-05 10-Q 10-Q 0001558370-21-010563 001-36721 211148492 34 10097757 1 1
2021-08-05 8-K 8-K 2.02,9.01 0001558370-21-010536 001-36721 211148158 34 498657 1 1
2021-07-08 4 FORM 4 0001567619-21-013149 7913
2021-06-10 4 FORM 4 0001567619-21-011972 5463
2021-06-08 4 FORM 4 0001567619-21-011842 14066
2021-05-26 8-K FORM 8-K 5.02,5.07 0001193125-21-172876 001-36721 21962673 34 154890 1 1
2021-05-25 4 FORM 4 0001567619-21-011154 5624
2021-05-25 4 FORM 4 0001567619-21-011153 5725
2021-05-06 10-Q 10-Q 0001558370-21-006257 001-36721 21898363 34 11161342 1 1
2021-05-06 8-K 8-K 2.02,9.01 0001558370-21-006248 001-36721 21898200 34 395656 1 1
2021-04-30 4 FORM 4 0001567619-21-008805 5327
2021-04-30 4 FORM 4 0001567619-21-008804 7704
2021-04-30 4 FORM 4 0001567619-21-008803 5291
2021-04-09 DEFA14A DEFA14A 0001558370-21-004120 001-36721 21817906 34 281190
2021-04-09 DEF 14A DEF 14A 0001558370-21-004117 001-36721 21817873 34 1282549
2021-03-16 3 FORM 3 0001567619-21-006437 12218
2021-03-11 4 FORM 4 0001567619-21-006128 16714
2021-03-09 4 FORM 4 0001567619-21-005917 10669
2021-02-25 10-K 10-K 0001558370-21-001829 001-36721 21680603 34 13943410 1 1
2021-02-24 8-K 8-K 2.02,9.01 0001558370-21-001589 001-36721 21673057 34 496771 1 1
2021-02-19 4 FORM 4 0001567619-21-004508 9174
2021-02-16 SC 13G/A SC 13G/A 0001193125-21-044723 005-88402 21637250 34 66037
2021-02-12 8-K 8-K 5.02 0001558370-21-000976 001-36721 21628587 34 168366 1 1
2021-02-10 SC 13G SCHEDULE 13G 0001104659-21-017790 005-88402 21610421 34 13997
2021-02-08 SC 13G Coherus_Biosciences_Inc.txt 0000093751-21-000099 005-88402 21598665 34 8590
2021-02-08 SC 13G SEC SCHEDULE 13G 0001532155-21-000022 005-88402 21597737 34 18328
2021-02-03 4 FORM 4 0001567619-21-002144 5746
2021-02-03 4 FORM 4 0001567619-21-002142 5750
2021-02-03 4 FORM 4 0001567619-21-002141 8869
2021-02-02 8-K 8-K 1.01,3.02,7.01,8.01,9.01 0001558370-21-000635 001-36721 21579153 34 261687 1 1
2021-01-27 4 FORM 4 0001567619-21-001600 10373
2021-01-26 4 FORM 4 0001567619-21-001529 5726
2021-01-26 SC 13G/A us19249h1032_012621.txt 0000834237-21-001331 005-88402 21553332 34 13478
2021-01-21 4 FORM 4 0001567619-21-001335 9177
2021-01-13 4 FORM 4 0001567619-21-000990 5646
2021-01-13 4 FORM 4 0001567619-21-000989 5661
2021-01-13 4 FORM 4 0001567619-21-000987 5657
2021-01-13 4 FORM 4 0001567619-21-000986 5658
2021-01-13 4 FORM 4 0001567619-21-000985 5689
2021-01-13 4 FORM 4 0001567619-21-000984 5538
2021-01-13 4 FORM 4 0001567619-21-000983 7728
2021-01-13 4 FORM 4 0001567619-21-000982 7700
2021-01-13 4 FORM 4 0001567619-21-000981 7764
2021-01-12 4 FORM 4 0001567619-21-000923 4989
2021-01-12 4 FORM 4 0001567619-21-000922 4783
2021-01-12 4 FORM 4 0001567619-21-000921 4847
2021-01-08 SC 13G FILING COHERUS BIOSCIENCES, INC. 0000019617-21-000030 005-88402 34 89994
2021-01-07 4 FORM 4 0001567619-21-000738 5630
2021-01-07 3 FORM 3 0001567619-21-000736 10704
2021-01-07 4 FORM 4 0001567619-21-000735 5731
2021-01-07 3 FORM 3 0001567619-21-000734 11355
2021-01-07 8-K 8-K 5.02,9.01 0001558370-21-000087 001-36721 21514366 34 204711 1 1
2021-01-04 S-8 S-8 0001558370-21-000016 333-251877 21502010 33 171577
2021-01-04 S-8 S-8 0001558370-21-000014 333-251876 21501872 33 199496
2020-12-21 4 FORM 4 0001567619-20-021405 9178
2020-12-11 4 FORM 4 0001567619-20-020979 14428
2020-12-09 4 FORM 4 0001567619-20-020818 12861
2020-12-07 4 FORM 4 0001567619-20-020705 22214
2020-11-19 4 FORM 4 0001567619-20-020096 18080

Latest XBRL company facts

One latest value per concept from companyfacts (521 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 154.54M 2026-10-31 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
dei EntityPublicFloat Entity Public Float USD 81.90M 2025-06-30 2025 FY 10-K 2026-03-09 0001104659-26-025308
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.06M 2025-01-01 2025-12-31 DEF 14A 2026-04-20 0001104659-26-045251
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.17M 2025-01-01 2025-12-31 DEF 14A 2026-04-20 0001104659-26-045251
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 2.84M 2025-01-01 2025-12-31 DEF 14A 2026-04-20 0001104659-26-045251
ecd PeoTotalCompAmt PeoTotalCompAmt USD 2.74M 2025-01-01 2025-12-31 DEF 14A 2026-04-20 0001104659-26-045251
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 18 2025-01-01 2025-12-31 DEF 14A 2026-04-20 0001104659-26-045251
ffd NetFeeAmt NetFeeAmt USD 1,531.25 2026-08-03 S-8 2026-08-05 0001104659-26-091276
ffd TtlFeeAmt TtlFeeAmt USD 1,531.25 2026-08-03 S-8 2026-08-05 0001104659-26-091276
ffd TtlOfferingAmt TtlOfferingAmt USD 11.09M 2026-08-03 S-8 2026-08-05 0001104659-26-091276
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-03 S-8 2026-08-05 0001104659-26-091276
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 14.51M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 50,000 2019-06-30 2019 Q2 10-Q 2019-08-05 0001564590-19-028841
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 1.86M 2016-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap AccountsReceivableRelatedPartiesCurrent Accounts Receivable, Related Parties, Current USD 278,000 2013-12-31 2014 Q3 10-Q 2014-12-15 0001564590-14-006207
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 3.05M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001558370-24-003436
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 7.80M 2014-09-30 2014 Q3 10-Q 2014-12-15 0001564590-14-006207
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 15.78M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 697,000 2016-03-31 2016 Q1 10-Q 2016-05-09 0001564590-16-018615
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 1.50M 2024-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties USD 38.40M 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap AccruedUtilitiesCurrent Accrued Utilities, Current USD 6.18M 2015-06-30 2015 Q2 10-Q 2015-08-10 0001564590-15-006845
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 900,000 2023-03-31 2023 Q1 10-Q 2023-05-08 0001558370-23-008529
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -287,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.51B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.03B 2020-09-30 2020 Q3 10-Q 2020-11-05 0001558370-20-012864
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 15.54M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-23 0001564590-15-001896
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 112,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 3.70M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 52,000 2024-04-01 2024-06-30 2025 Q3 10-Q 2025-11-06 0001104659-25-107852
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 8.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 44.01M 2019-06-30 2019 Q2 10-Q 2019-08-05 0001564590-19-028841
us-gaap AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) USD 97.16M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-05 0001564590-19-028841
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 4.16M 2024-01-01 2024-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 3.90M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-23 0001564590-15-001896
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 1.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 33.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 47,789 2015-07-31 2020 Q1 10-Q 2020-05-07 0001558370-20-005749
us-gaap Assets Assets USD 171.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap AssetsCurrent Assets, Current USD 114.13M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 191.65M 2022-12-31 2023 FY 10-K 2024-03-15 0001558370-24-003436
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 138.97M 2025-03-31 2025 Q1 10-Q 2025-05-12 0001558370-25-007418
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 72.18M 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 80,000 2025-12-31 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 15,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 82.52M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 82.50M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap AvailableForSaleSecuritiesGrossRealizedGains Available-for-sale Securities, Gross Realized Gains USD 459,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028562
us-gaap AvailableForSaleSecuritiesGrossRealizedLosses Available-for-sale Securities, Gross Realized Losses USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028562
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 42,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 6.50M 2014-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013726
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 3.30M 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 632,000 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized Business Combination, Liabilities Arising from Contingencies, Amount Recognized USD 0 2025-04-30 8-K 2025-11-13 0001104659-25-111484
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 2.33M 2014-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013726
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets USD 107,000 2014-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013726
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities USD 1.03M 2014-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013726
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net USD 4.98M 2014-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013726
us-gaap CapitalizedComputerSoftwareNet Capitalized Computer Software, Net USD 600,000 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 7.00M 2023-01-01 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 53.49M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 1.96M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 83.60M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 53.58M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 177.91M 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -35.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 230,795 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 154.53M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 154.53M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap CommonStockValue Common Stock, Value, Issued USD 15,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 132.53M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD -70,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -98.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 81.36M 2021-12-31 2021 FY 10-K 2022-02-23 0001558370-22-001764
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 80.98M 2021-09-30 2021 Q3 10-Q 2021-11-08 0001558370-21-015033
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 21.32M 2014-11-12 2015 FY 10-K 2016-02-29 0001564590-16-013726
us-gaap ConvertibleSubordinatedDebtNoncurrent Convertible Subordinated Debt, Noncurrent USD 228.23M 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 12.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap CostsAndExpenses Costs and Expenses USD 143.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 3.46M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002917
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 3.46M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002917
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 10.63M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-23 0001564590-15-001896
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 133.60M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001564590-19-042255
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 0 2014-01-01 2014-09-30 2014 FY 10-K 2015-03-23 0001564590-15-001896
us-gaap DebtInstrumentConvertibleThresholdTradingDays Debt Instrument, Convertible, Threshold Trading Days item 15 2016-02-29 2022 FY 10-K 2023-03-06 0001558370-23-002917
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 75.00M 2019-12-31 2020 Q1 10-Q 2020-05-07 0001558370-20-005749
us-gaap DebtInstrumentFeeAmount Debt Instrument, Fee Amount USD 9.00M 2016-02-29 2021 FY 10-K 2022-02-23 0001558370-22-001764
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.12 2025-10-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.021 2026-06-30 2026 Q2 10-Q 2026-08-05 0001104659-26-091262
us-gaap DebtInstrumentRedemptionPricePercentage Debt Instrument, Redemption Price, Percentage pure 1 2025-05-15 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DebtInstrumentRepurchaseAmount Debt Instrument, Repurchase Amount USD 59.90M 2025-05-15 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 1.34M 2019-12-31 2020 Q1 10-Q 2020-05-07 0001558370-20-005749
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions security 0 2021-09-30 2021 Q3 10-Q 2021-11-08 0001558370-21-015033
us-gaap DebtSecuritiesAvailableForSaleRealizedGain Debt Securities, Available-for-sale, Realized Gain USD 293,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-08 0001564590-19-042255
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001558370-20-012864
us-gaap DebtSecuritiesAvailableForSaleRealizedLoss Debt Securities, Available-for-sale, Realized Loss USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-08 0001564590-19-042255
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD 0 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-06 0001558370-23-017779
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions position 1 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible Decrease in Unrecognized Tax Benefits is Reasonably Possible USD 6.40M 2016-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -380,000 2023-01-01 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -380,000 2023-01-01 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 8.53M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 1.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2016-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 892,000 2016-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 669,000 2016-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 531,000 2016-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 375.55M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 44.96M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 7.43M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 174.24M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 26.60M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 74.84M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 18.00M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 31.62M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Returns and Allowances USD 5.29M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 368.12M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 1.10M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 5.83M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 800,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.5 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.9 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 2.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DerivativeAssetNotionalAmount Derivative Asset, Notional Amount USD 2.55M 2023-06-30 2023 Q2 10-Q 2023-08-02 0001558370-23-012915
us-gaap DerivativeAssets Derivative Asset USD 0 2023-12-31 2023 FY 10-K 2024-03-15 0001558370-24-003436
us-gaap DerivativeAssetsCurrent Derivative Asset, Current USD 8,000 2023-06-30 2023 Q2 10-Q 2023-08-02 0001558370-23-012915
us-gaap DerivativeLiabilities Derivative Liability USD 0 2023-12-31 2023 FY 10-K 2024-03-15 0001558370-24-003436
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 13.62M 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 1.49M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap DerivativeLiabilityNotionalAmount Derivative Liability, Notional Amount USD 3.60M 2023-06-30 2023 Q2 10-Q 2023-08-02 0001558370-23-012915
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax USD 10.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share USD/shares 0.07 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share USD/shares 0.07 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current USD 11.48M 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 44.24M 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DisposalGroupIncludingDiscontinuedOperationConsideration Disposal Group, Including Discontinued Operation, Consideration USD 170.00M 2024-03-01 2024 Q3 10-Q 2024-11-06 0001558370-24-014648
us-gaap DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold Disposal Group, Including Discontinued Operation, Costs of Goods Sold USD 158.55M 2023-01-01 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap DisposalGroupIncludingDiscontinuedOperationInterestExpense Disposal Group, Including Discontinued Operation, Interest Expense USD 3.48M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap DisposalGroupIncludingDiscontinuedOperationOperatingExpense Disposal Group, Including Discontinued Operation, Operating Expense USD 0 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-15 0001558370-24-003436
us-gaap DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss Disposal Group, Including Discontinued Operation, Operating Income (Loss) USD 11.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent USD 9.00M 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment Disposal Group, Including Discontinued Operation, Property, Plant and Equipment USD 261,000 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap DisposalGroupIncludingDiscontinuedOperationRevenue Disposal Group, Including Discontinued Operation, Revenue USD 11.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD -1.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 0 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 0 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.66 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.92 2018-10-01 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.66 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.002 2023-01-01 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.155 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.003 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002917
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.066 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.004 2024-01-01 2024-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment Effective Income Tax Rate Reconciliation, Tax Credit, Investment, Percent pure 0.007 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations USD -120,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -276,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-23 0001558370-22-001764
us-gaap EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability Embedded Derivative, Fair Value of Embedded Derivative Liability USD 9.20M 2024-06-30 2024 Q2 10-Q 2024-08-08 0001558370-24-011629
us-gaap EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet Embedded Derivative, Fair Value of Embedded Derivative, Net USD 0 2013-12-31 2014 FY 10-K 2015-03-23 0001564590-15-001896
us-gaap EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet Embedded Derivative, Gain (Loss) on Embedded Derivative, Net USD 12.60M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap EmbeddedDerivativeLossOnEmbeddedDerivative Embedded Derivative, Loss on Embedded Derivative USD 4.10M 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-23 0001564590-15-001896
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 11.97M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 79,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 10.70M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 15.90M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-09-30 2022 Q3 10-Q 2022-11-08 0001558370-22-016850
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-09-30 2022 Q3 10-Q 2022-11-08 0001558370-22-016850
us-gaap FairValueInputsDiscountRate Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) pure 0.3 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-23 0001564590-15-001896
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2022-09-30 2022 Q3 10-Q 2022-11-08 0001558370-22-016850
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2022-09-30 2022 Q3 10-Q 2022-11-08 0001558370-22-016850
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-08 0001558370-23-008529
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 9.85M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-08 0001558370-23-008529
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3 Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers into Level 3 USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers, Net USD 0 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-06 0001558370-20-009657
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3 Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers out of Level 3 USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 24,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 248,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 1.07M 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 721,000 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 351,000 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 1.14M 2023-12-31 2023 FY 10-K 2024-03-15 0001558370-24-003436
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 781,000 2023-12-31 2023 FY 10-K 2024-03-15 0001558370-24-003436
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 25,000 2020-03-31 2020 Q1 10-Q 2020-05-07 0001558370-20-005749
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 481,000 2022-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002917
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 358,000 2023-12-31 2023 FY 10-K 2024-03-15 0001558370-24-003436
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 530,000 2021-03-31 2021 Q1 10-Q 2021-05-06 0001558370-21-006257
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 67,000 2023-12-31 2023 FY 10-K 2024-03-15 0001558370-24-003436
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 24,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 1.02M 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 225,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.087 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 24.25M 2013-12-31 2014 FY 10-K 2015-03-23 0001564590-15-001896
us-gaap FinancingReceivableAllowanceForCreditLosses Financing Receivable, Allowance for Credit Loss USD 0 2021-03-31 2021 Q1 10-Q 2021-05-06 0001558370-21-006257
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 6.88M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 18.13M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap ForeignCurrencyTransactionGainBeforeTax Foreign Currency Transaction Gain, before Tax USD 91,000 2015-01-01 2015-03-31 2016 Q1 10-Q 2016-05-09 0001564590-16-018615
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -333,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap ForeignCurrencyTransactionLossBeforeTax Foreign Currency Transaction Loss, before Tax USD 264,000 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-09 0001564590-16-018615
us-gaap GainLossOnContractTermination Gain (Loss) on Contract Termination USD -3.21M 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-15 0001558370-24-003436
us-gaap GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments USD 82,000 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0001558370-23-017779
us-gaap GainLossOnSaleOfInterestInProjects Gain (Loss) on Sale of Interest in Projects USD -1.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap GainLossOnSalesOfAssetsAndAssetImpairmentCharges Gain (Loss) on Sale of Assets and Asset Impairment Charges USD -110,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -3.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 60.34M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028562
us-gaap Goodwill Goodwill USD 943,000 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001558370-24-003436
us-gaap GoodwillWrittenOffRelatedToSaleOfBusinessUnit Goodwill, Written off Related to Sale of Business Unit USD 900,000 2024-03-01 2024 Q1 10-Q 2024-05-09 0001558370-24-007641
us-gaap GrossProfit Gross Profit USD 116.05M 2019-10-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap GuaranteeObligationsCurrentCarryingValue Guarantor Obligations, Current Carrying Value USD 50,000 2015-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2023-01-01 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-23 0001558370-22-001764
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 100,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 8,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-09 0001564590-16-028634
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -183.12M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -109.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -8,000 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-17 0001558370-25-003126
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 135.71M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -109.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.73 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.73 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 10.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap IncomeTaxesPaid Income Taxes Paid USD 40,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002917
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 36,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 28.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -38.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 12.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -277,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD -237,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 4.02M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-05 0001564590-19-028841
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD -233,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 4.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -1.86M 2017-01-01 2017-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap IncreaseDecreaseInAccountsReceivableRelatedParties Increase (Decrease) in Accounts Receivable, Related Parties USD -278,000 2014-01-01 2014-09-30 2015 Q3 10-Q 2015-11-10 0001564590-15-010330
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -9,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -8.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -168,000 2017-01-01 2017-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012976
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD -1.69M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD -1.69M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-23 0001564590-15-001896
us-gaap IncreaseDecreaseInDueToRelatedPartiesCurrent Increase (Decrease) in Due to Related Parties, Current USD 1.19M 2014-01-01 2014-03-31 2015 Q1 10-Q 2015-05-11 0001564590-15-003938
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 10.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap IncreaseDecreaseInNotesReceivableCurrent Increase (Decrease) in Notes Receivable, Current USD -1.85M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent Increase (Decrease) in Notes Receivable, Related Parties, Current USD -107,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -389,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001564590-15-003938
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 78,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 1.78M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 949,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -130,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD 45.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -4.49M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001104659-26-058703
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD -1.02M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD -4.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 785,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-10 0001564590-15-010330
us-gaap IncreaseInRestrictedCash Increase in Restricted Cash USD 785,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap IncrementalCommonSharesAttributableToContingentlyIssuableShares Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares shares 108,533 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001558370-25-003126
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 11.94M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0001558370-24-014648
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 168,392 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001558370-25-003126
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 26.24M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 71.67M 2023-12-31 2023 FY 10-K 2024-03-15 0001558370-24-003436
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 44.36M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap InterestExpense Interest Expense USD 7.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap InterestExpenseDebt Interest Expense, Debt USD 5.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 2.54M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-23 0001558370-22-001764
us-gaap InterestOnConvertibleDebtNetOfTax Interest on Convertible Debt, Net of Tax USD 3.59M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0001558370-24-014648
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 8.20M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 9.92M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 7.07M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap InventoryGross Inventory, Gross USD 14.18M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap InventoryNet Inventory, Net USD 4.82M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 9.35M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 18.01M 2024-12-31 2024 FY 10-K 2025-03-17 0001558370-25-003126
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 26.00M 2022-09-30 2022 Q3 10-Q 2022-11-08 0001558370-22-016850
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 7.11M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap InventoryWriteDown Inventory Write-down USD 14.14M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 7.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 147,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 2.20M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap LeaseCost Lease, Cost USD 2.07M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 3.10M 2015-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013726
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 3.66M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 700,000 2020-03-31 2020 Q1 10-Q 2020-05-07 0001558370-20-005749
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.13M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 700,000 2020-09-30 2020 Q3 10-Q 2020-11-05 0001558370-20-012864
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.53M 2023-12-31 2023 FY 10-K 2024-03-15 0001558370-24-003436
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.53M 2024-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.53M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 2.57M 2021-03-31 2021 Q1 10-Q 2021-05-06 0001558370-21-006257
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 371,000 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap Liabilities Liabilities USD 145.85M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 171.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap LiabilitiesCurrent Liabilities, Current USD 75.64M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment USD 900,000 2023-01-01 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 11.48M 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 9.00M 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 1.40M 2017-04-01 2017-06-30 2018 Q1 10-Q 2018-05-10 0001564590-18-012976
us-gaap LitigationReserveCurrent Estimated Litigation Liability, Current USD 4.70M 2022-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002917
us-gaap LitigationSettlementAmount Litigation Settlement, Amount (Deprecated 2017-01-31) USD 0 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-10 0001564590-15-006845
us-gaap LoansPayableCurrent Loans Payable, Current USD 175.00M 2024-03-31 2024 Q1 10-Q 2024-05-09 0001558370-24-007641
us-gaap LongTermDebt Long-term Debt USD 73.66M 2019-12-31 2020 Q1 10-Q 2020-05-07 0001558370-20-005749
us-gaap LongTermDebtFairValue Long-term Debt, Fair Value USD 0 2013-12-31 2014 FY 10-K 2015-03-23 0001564590-15-001896
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 75.51M 2021-12-31 2021 FY 10-K 2022-02-23 0001558370-22-001764
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap MarketableSecurities Marketable Securities USD 0 2022-03-31 2023 Q1 10-Q 2023-05-08 0001558370-23-008529
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 30.14M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0001558370-22-007420
us-gaap MarketingAndAdvertisingExpense Marketing and Advertising Expense USD 6.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD -1.29M 2017-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders USD 2.13M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap MinorityInterestDecreaseFromRedemptions Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests USD 1.36M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 65.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 1.88M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012976
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 52.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -13.18M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012976
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -154.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -33.58M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012976
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -98.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -70,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD 82.79M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0001558370-24-014648
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -189.10M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-06 0001564590-17-021844
us-gaap NotesAndLoansReceivableNetCurrent Financing Receivable, after Allowance for Credit Loss, Current USD 1.81M 2014-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013726
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 3.09M 2013-12-31 2014 FY 10-K 2015-03-23 0001564590-15-001896
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 27.12M 2021-12-31 2021 FY 10-K 2022-02-23 0001558370-22-001764
us-gaap NotesReceivableRelatedParties Notes Receivable, Related Parties USD 133,000 2011-12-31 2014 Q3 10-Q 2014-12-15 0001564590-14-006207
us-gaap NotesReceivableRelatedPartiesCurrent Notes Receivable, Related Parties, Current USD 107,000 2013-12-31 2014 FY 10-K 2015-03-23 0001564590-15-001896
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap OperatingExpenses Operating Expenses USD 225.51M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001558370-20-012864
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -102.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.07M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 2.40M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 3.29M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.95M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.46M 2025-12-31 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.95M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 10.54M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.66M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 2.52M 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 2.52M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 2.67M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 2.69M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 5.19M 2016-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 439,000 2016-09-30 2016 Q3 10-Q 2016-11-09 0001564590-16-028634
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.121 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 11.96M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap OtherAdjustmentsToIncomeDiscontinuedOperations Other Adjustments to Income, Discontinued Operations USD 8.70M 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001104659-25-107852
us-gaap OtherAssetsCurrent Other Assets, Current USD 83,000 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 2.61M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -3,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -6,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -95,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 3.86M 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 17.67M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap OtherNoncashExpense Other Noncash Expense USD 3.90M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-12-15 0001564590-14-006207
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 39,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-10 0001564590-15-006845
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 3.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD -11.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 2.38M 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap OtherSalesRevenueNet Other Revenue, Net (Deprecated 2018-01-31) USD 630,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap OtherSundryLiabilitiesNoncurrent Other Sundry Liabilities, Noncurrent USD 24,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 1.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap PaymentsForProceedsFromProductiveAssets Payments for (Proceeds from) Productive Assets USD -478.68M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 2,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap PaymentsForRestructuring Payments for Restructuring USD 2.10M 2018-01-01 2018-03-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap PaymentsForUnderwritingExpense Payments for Underwriting Expense USD 3.00M 2016-05-01 2016-06-30 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 739,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 40,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 112,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-05 0001104659-26-091262
us-gaap PaymentsToAcquireInterestInSubsidiariesAndAffiliates Payments to Acquire Interest in Subsidiaries and Affiliates USD 300,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 50.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 286,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001558370-24-003436
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 5.83M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 18.36M 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap PriorPeriodReclassificationAdjustment Prior Period Reclassification Adjustment USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001558370-24-003436
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 222.16M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002917
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 52.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 6.83M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-08 0001558370-23-008529
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 53.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 54.66M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 36.98M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0001558370-24-014648
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 7.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 53,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 25.00M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 104.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 8.69M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 187.82M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0001558370-24-007641
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 845,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001558370-24-003436
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 291,000 2024-01-01 2024-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 202,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 131,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap ProductionRelatedImpairmentsOrCharges Production Related Impairments or Charges USD 3.20M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002917
us-gaap ProductLiabilityContingencyLossExposureNotAccruedBestEstimate Product Liability Contingency, Loss Exposure Not Accrued, Best Estimate USD 14.00M 2022-04-01 2022-04-30 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -98.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization USD 20.99M 2024-12-31 2024 FY 10-K 2025-03-17 0001558370-25-003126
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization USD 652,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization USD 23.82M 2024-12-31 2024 FY 10-K 2025-03-17 0001558370-25-003126
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 27.78M 2020-06-30 2020 Q2 10-Q 2020-08-06 0001558370-20-009657
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.34M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 30.72M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-09 0001564590-19-018007
us-gaap ProvisionForLoanLossesExpensed Financing Receivable, Credit Loss, Expense (Reversal) USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-08 0001558370-21-015033
us-gaap PurchaseObligation Purchase Obligation USD 5.30M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap PurchaseObligationDueInFourthYear Purchase Obligation, to be Paid, Year Four USD 150,000 2025-03-31 2025 Q1 10-Q 2025-05-12 0001558370-25-007418
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 3.70M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap PurchaseObligationDueInSecondYear Purchase Obligation, to be Paid, Year Two USD 16.45M 2024-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap PurchaseObligationDueInThirdYear Purchase Obligation, to be Paid, Year Three USD 600,000 2024-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear Purchase Obligation, to be Paid, Remainder of Fiscal Year USD 1.60M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 13.72M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap ReceivableWithImputedInterestEffectiveYieldInterestRate Receivable with Imputed Interest, Effective Yield (Interest Rate) pure 0.04 2011-12-01 2011-12-31 2014 Q3 10-Q 2014-12-15 0001564590-14-006207
us-gaap RecordedUnconditionalPurchaseObligationDueInFifthYear Recorded Unconditional Purchase Obligation, to be Paid, Year Five USD 179,000 2021-12-31 2021 FY 10-K 2022-02-23 0001558370-22-001764
us-gaap RelatedPartyTransactionDueFromToRelatedPartyCurrent Related Party Transaction, Due from (to) Related Party, Current USD 0 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party USD 1,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 121,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap RepaymentsOfDebt Repayments of Debt USD 40.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 65.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap RestrictedCash Restricted Cash USD 263,000 2024-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 50,000 2018-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 440,000 2022-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002917
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap RestructuringCharges Restructuring Charges USD 3.60M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap RestructuringReserve Restructuring Reserve USD 0 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.48B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer USD 300,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0001558370-24-007641
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 123.86M 2019-10-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 40.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap Revenues Revenues USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 2.69M 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-17 0001558370-25-003126
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 2.65M 2023-01-01 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap RoyaltyIncomeNonoperating Royalty Income, Nonoperating USD 1.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 1.55M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 1.56M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 65.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 8.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.75 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.014 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 2.56M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 540,489 2016-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 435,000 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 18.24M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 10.91 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 18,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 5.68M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 6.26M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.86 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 2.33M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 29.25M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 7.59 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 58.17B 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 11.87M 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 14.974 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 22.37M 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 14.67M 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 14.202 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 15.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0.77 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 13.33 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.23 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap SharePrice Share Price USD/shares 1.38 2024-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 18 2016-06-30 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 25.25M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 105.21M 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007416
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 1 2014-11-11 2014-11-12 2015 FY 10-K 2016-02-29 0001564590-16-013726
us-gaap StockIssued1 Stock Issued USD 4.41M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 650,005 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 35,500 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 58.54M 2023-01-01 2023-12-31 8-K 2025-11-13 0001104659-25-111484
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 202,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 48,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 53.65M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 7.06M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-08 0001558370-23-008529
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 50,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 2,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004176
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 54.70M 2013-12-31 2014 FY 10-K 2015-03-23 0001564590-15-001896
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 58.28M 2013-12-31 2014 FY 10-K 2015-03-23 0001564590-15-001896
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 28.09M 2013-12-31 2014 FY 10-K 2015-03-23 0001564590-15-001896
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 9.15M 2013-12-31 2014 FY 10-K 2015-03-23 0001564590-15-001896
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2014-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013726
us-gaap TimeSharingTransactionsWeightedAverageOfStatedInterestRatesForNotesReceivable1 Time Sharing Transactions, Weighted Average of Stated Interest Rates for Notes Receivable (Deprecated 2016-01-31) pure 0.002 2011-12-01 2011-12-31 2014 Q3 10-Q 2014-12-15 0001564590-14-006207
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001829
us-gaap UnrealizedGainLossOnSecurities Unrealized Gain (Loss) on Securities USD 0 2022-01-01 2022-03-31 2023 Q1 10-Q 2023-05-08 0001558370-23-008529
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 20.02M 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 280,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005470
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 1.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 265,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -44.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001104659-26-025308
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 114.83M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001558370-25-003126
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 148.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 74.20M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-05 0001558370-21-010563
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 3,609 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004947
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 148.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124572

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →